Therapeutic Applications of Oleanolic Acid: Molecular Mechanisms and Clinical Perspectives

People in developing nations have long used plants as an adjunct or alternative treatment for chronic illnesses. Researchers are concentrating their efforts on finding the bioactive chemicals in plants and their products because of their obvious therapeutic. Human health benefits from an increase in the consumption of plant-based diets. A pentacyclic triterpene, Oleanolic Acid (OA), is present in a variety of plants and serves as an aglycone precursor or free acid for a number of triterpenoid saponins. With strong antibacterial, antioxidant, antitumor, anti-inflammatory, anti-diabetic, and neuroprotective qualities, OA and its derivatives are thought to be promising compounds. Since OA is hydrophobic in nature, it has historically been regarded as a low-bioavailable biomolecule. More recent research, however, has demonstrated that delivering it in lipophilic matrices can greatly increase its bioavailability. Oleanolic acid has been quantified using a variety of analytical techniques to ensure its efficacy, safety, and quality. It provides a framework for both industry and regulatory bodies to establish and maintain high standards in the production and its medicinal value. The goal of this review is to give an overview of the therapeutic potential of oleanolic acid against various diseases based on preclinical and clinical research. Major Findings: This review shows strong preclinical efficacy in diabetes, cancer, liver injury, and neurodegeneration, with early clinical evidence supporting metabolic and anti-inflammatory benefits. Its market uptake is growing through clean-label functional foods and cosmeceuticals, while advances in semi-synthetic derivatives are enhancing bioavailability and driving clinical development.